HLN (Haleon) Gross Profit : $8,755 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Gross Profit?

Haleon's gross profit for the three months ended in Dec. 2024 was $1,932 Mil. Haleon's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $8,755 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Haleon's gross profit for the three months ended in Dec. 2024 was $1,932 Mil. Haleon's Revenue for the three months ended in Dec. 2024 was $3,488 Mil. Therefore, Haleon's Gross Margin % for the quarter that ended in Dec. 2024 was 55.38%.

Haleon had a gross margin of 55.38% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 6 years, the highest Gross Margin % of Haleon was 62.34%. The lowest was 56.63%. And the median was 60.16%.

Haleon Gross Profit Historical Data

The historical data trend for Haleon's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Gross Profit Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Gross Profit

Get a 7-Day Free Trial

7,943.55

7,912.23

8,010.96

8,540.51

8,627.05

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Gross Profit	Get a 7-Day Free Trial												1,874.68	2,335.45	2,175.57	2,312.17	1,931.73

Competitive Comparison of Haleon's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Gross Profit distribution charts can be found below:

* The bar in red indicates where Haleon's Gross Profit falls into.

Save Embed

;

Save Embed

;

Haleon Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Haleon's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )	=	Revenue	-	Cost of Goods Sold
	=	14201.011	-	5573.957
	=	8,627

Haleon's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )	=	Revenue	-	Cost of Goods Sold
	=	3487.99	-	1556.258
	=	1,932

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8,755 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Haleon's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )	=	Gross Profit (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	1,932	/	3487.99
	=	55.38 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Haleon (NYSE:HLN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Haleon had a gross margin of 55.38% for the quarter that ended in Dec. 2024 => Durable competitive advantage

Haleon Gross Profit Related Terms

Thank you for viewing the detailed overview of Haleon's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN1:Mexico HLN:Mexico HLNl:UK HLN:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.